Endo begins shipping generic CellCept

DUBLIN — Endo announced Tuesday that Par Pharmaceutical had begun shipping its generic CellCept (mycophenolate mofetil hydrochloride) for injection. 

 

The drug had about $42 million in U.S. sales for the 12 months ended Oct. 31, 2016, according to Quintiles IMS data. Par’s generic is packaged in cartons of four 500-mg single-dose vials.